glp-1 agonists cardiovascular diseases receptor and outcome trials: An update GLP-1RAs reduce cardiovascular deaths in
Description
Validation of a mathematical model for ultrasound assessment of gastric volume by gastroscopic examination
Cardiovascular disease and risk management: standards of medical care in diabetes2021
The reporting items were followed by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines ( Supplementary Table 3 )
Among the companies that took up the gauntlet was Novo Nordisk, a Danish company which grew out of one founded in 1923 to produce insulin (figure 36)
